Your browser doesn't support javascript.
loading
Exploratory Analysis of TP53 Mutations in Circulating Tumour DNA as Biomarkers of Treatment Response for Patients with Relapsed High-Grade Serous Ovarian Carcinoma: A Retrospective Study.
Parkinson, Christine A; Gale, Davina; Piskorz, Anna M; Biggs, Heather; Hodgkin, Charlotte; Addley, Helen; Freeman, Sue; Moyle, Penelope; Sala, Evis; Sayal, Karen; Hosking, Karen; Gounaris, Ioannis; Jimenez-Linan, Mercedes; Earl, Helena M; Qian, Wendi; Rosenfeld, Nitzan; Brenton, James D.
Afiliação
  • Parkinson CA; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.
  • Gale D; Department of Oncology, Hutchison/MRC Research Centre, University of Cambridge, Cambridge, United Kingdom.
  • Piskorz AM; NIHR Cambridge Biomedical Research Centre, Cambridge, United Kingdom.
  • Biggs H; Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
  • Hodgkin C; Cancer Research UK Major Centre-Cambridge, Cancer Research UK Cambridge Institute, Cambridge, United Kingdom.
  • Addley H; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.
  • Freeman S; Cancer Research UK Major Centre-Cambridge, Cancer Research UK Cambridge Institute, Cambridge, United Kingdom.
  • Moyle P; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.
  • Sala E; Cancer Research UK Major Centre-Cambridge, Cancer Research UK Cambridge Institute, Cambridge, United Kingdom.
  • Sayal K; Department of Oncology, Hutchison/MRC Research Centre, University of Cambridge, Cambridge, United Kingdom.
  • Hosking K; NIHR Cambridge Biomedical Research Centre, Cambridge, United Kingdom.
  • Gounaris I; Cancer Research UK Major Centre-Cambridge, Cancer Research UK Cambridge Institute, Cambridge, United Kingdom.
  • Jimenez-Linan M; Department of Oncology, Hutchison/MRC Research Centre, University of Cambridge, Cambridge, United Kingdom.
  • Earl HM; Cancer Research UK Major Centre-Cambridge, Cancer Research UK Cambridge Institute, Cambridge, United Kingdom.
  • Qian W; Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
  • Rosenfeld N; Cancer Research UK Major Centre-Cambridge, Cancer Research UK Cambridge Institute, Cambridge, United Kingdom.
  • Brenton JD; Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.
PLoS Med ; 13(12): e1002198, 2016 Dec.
Article em En | MEDLINE | ID: mdl-27997533
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / DNA de Neoplasias / Carcinoma / Proteína Supressora de Tumor p53 Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / DNA de Neoplasias / Carcinoma / Proteína Supressora de Tumor p53 Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article